45 small and medium-sized enterprises (SMEs) from 19 countries have been selected in the latest round of Horizon2020 SME Instrument Phase 2. Each project, 30 in total, will receive between €0.5 and €2.5 million (€5 million for health projects) to bring their product from pilot-phase to the market.
Despite decades of research, a cure for Alzheimer's remains elusive. But work conducted in Europe suggests that the onset and progression of the disease could be prevented or slowed down by a molecule that mimics the activity of a critical protein (neurotrophin) affecting neurons in the brain.
New vaccines could be developed more quickly and be better targeted to specific age groups, thanks to EU-funded research. A five-year project has been studying novel immunisation technologies, boosting international efforts in vaccine research.
Arthritis is very common - so common, indeed, that aching joints may seem inevitable as we age. They are not, of course, and even if the condition does set in, treatment can often slow it down. MRI combined with nanoparticles developed by an EU-funded project could soon help to spot main forms of the disease much earlier.
In its 2016 edition, the School on Neurotechniques, organised by the CSNII (Convergent Science Network for Biomimetics and Neurotechnology) FET project, will offer an overview on advanced electrical- and light-based recording methods of neuronal excitability, focusing on those that are most relevant for the investigation of neural networks ‘in vitro’ and ‘in vivo’ and for application in neuroprosthetics.
The European Research Council (ERC) announced today the 302 winners of its 2015 Consolidator Grant competition. These excellent mid-career scientists have been awarded a total of €585 million, as part of the EU's Research and Innovation programme, Horizon 2020.